Institute of Environmental Science and Research, Health Group, Porirua 5022, New Zealand.
Awanui Labs Wellington, Department of Microbiology and Molecular Pathology, Wellington 6021, New Zealand.
Microb Genom. 2024 Jul;10(7). doi: 10.1099/mgen.0.001273.
Outbreaks of methicillin-resistant (MRSA) are well described in the neonatal intensive care unit (NICU) setting. Genomics has revolutionized the investigation of such outbreaks; however, to date, this has largely been completed retrospectively and has typically relied on short-read platforms. In 2022, our laboratory established a prospective genomic surveillance system using Oxford Nanopore Technologies sequencing for rapid outbreak detection. Herein, using this system, we describe the detection and control of an outbreak of sequence-type (ST)97 MRSA in our NICU. The outbreak was identified 13 days after the first MRSA-positive culture and at a point where there were only two known cases. Ward screening rapidly defined the extent of the outbreak, with six other infants found to be colonized. There was minimal transmission once the outbreak had been detected and appropriate infection control measures had been instituted; only two further ST97 cases were detected, along with three unrelated non-ST97 MRSA cases. To contextualize the outbreak, core-genome single-nucleotide variants were identified for phylogenetic analysis after assembly of nanopore data. Comparisons with global (=45) and national surveillance (=35) ST97 genomes revealed the stepwise evolution of methicillin resistance within this ST97 subset. A distinct cluster comprising nine of the ten ST97-IVa genomes from the NICU was identified, with strains from 2020 to 2022 national surveillance serving as outgroups to this cluster. One ST97-IVa genome presumed to be part of the outbreak formed an outgroup and was retrospectively excluded. A second phylogeny was created using Illumina sequencing, which considerably reduced the branch lengths of the NICU isolates on the phylogenetic tree. However, the overall tree topology and conclusions were unchanged, with the exception of the NICU outbreak cluster, where differences in branch lengths were observed. This analysis demonstrated the ability of a nanopore-only prospective genomic surveillance system to rapidly identify and contextualize an outbreak of MRSA in a NICU.
耐甲氧西林金黄色葡萄球菌(MRSA)的爆发在新生儿重症监护病房(NICU)中已有详细描述。基因组学彻底改变了对这类爆发的调查;然而,迄今为止,这主要是通过回顾性研究完成的,并且通常依赖于短读长平台。2022 年,我们的实验室建立了一个使用牛津纳米孔技术测序的前瞻性基因组监测系统,用于快速检测爆发。在此,我们使用该系统描述了我们 NICU 中 ST97 型 MRSA 爆发的检测和控制。爆发是在首次 MRSA 阳性培养后 13 天发现的,当时只有两例已知病例。病房筛查迅速确定了爆发的范围,另外发现了六名婴儿定植。一旦发现爆发并采取适当的感染控制措施,传播就很少;仅发现另外两例 ST97 病例,以及三例无关的非 ST97 MRSA 病例。为了了解爆发的背景,在组装纳米孔数据后,对核心基因组单核苷酸变异进行了用于系统发育分析的识别。与全球(=45)和国家监测(=35)ST97 基因组的比较显示,该 ST97 亚组内的耐甲氧西林的逐步进化。从 NICU 中鉴定出的 10 个 ST97-IVa 基因组中的 9 个组成了一个独特的簇,该簇的菌株是作为该簇的外群来自 2020 年至 2022 年的国家监测。一个被认为是爆发一部分的 ST97-IVa 基因组形成外群并被追溯排除。使用 Illumina 测序创建了第二个系统发育树,该树大大缩短了 NICU 分离株在系统发育树上的分支长度。然而,总体树拓扑和结论保持不变,除了 NICU 爆发簇,在该簇中观察到分支长度的差异。这项分析表明,仅使用纳米孔的前瞻性基因组监测系统能够快速识别和阐明 NICU 中 MRSA 的爆发。